Grace Therapeutics Inc. (GRCE)
NASDAQ: GRCE
· Real-Time Price · USD
3.26
0.18 (5.84%)
At close: Aug 15, 2025, 3:59 PM
3.20
-1.83%
After-hours: Aug 15, 2025, 06:23 PM EDT
Grace Therapeutics Cash Flow Statement
Financials in USD. Fiscal
year is
April - March.
| Fiscal Year | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 |
Net Income | -10.31M | -9.57M | -13.37M | -11.61M | -11.45M | -12.85M | -38.77M | -40.27M | -41.93M | -42.43M | -17.25M | -17.14M | -11.22M | -9.82M | -11.56M | -11M | -18.13M |
Depreciation & Amortization | 8K | 7K | 6K | 5K | 5K | 11K | 18K | 27K | -36K | 124K | 116K | 106K | 167K | n/a | 1K | 1K | 376K |
Stock-Based Compensation | 794K | 730K | 829K | 995K | 1.07M | 913K | 1.01M | 1.12M | 1.43M | 1.81M | 2.1M | 2.12M | 1.65M | 1.34M | 892K | 408K | 695K |
Other Working Capital | -828K | -254K | 454K | 1.89M | 1.21M | -1.36M | -1.44M | -2.19M | -671K | 483K | 1.44M | 302K | -2.98M | -2.77M | -4.75M | -3.52M | -3.37M |
Other Non-Cash Items | -565K | -3.22M | 455K | -849K | 1.3M | 2.71M | 35.62M | 35.77M | 33.98M | 33.94M | -896K | -1.5M | -6.08M | -5.97M | -796K | 826K | 8.81M |
Deferred Income Tax | -2.48M | -3.2M | -3.07M | -2.67M | -2.27M | -1.83M | -9.81M | -9.88M | -9.59M | -9.54M | -671K | -397K | -242K | n/a | n/a | n/a | n/a |
Change in Working Capital | -558K | 342K | 1.11M | 2.31M | 1.65M | -1.28M | -1.63M | -2.17M | -574K | 181K | 860K | 212K | -3.52M | -2.79M | -4.38M | -5.71M | -5.3M |
Operating Cash Flow | -13.11M | -14.9M | -14.04M | -11.81M | -9.69M | -12.33M | -13.57M | -15.4M | -16.73M | -15.91M | -15.73M | -16.59M | -19.26M | -17.23M | -15.85M | -15.48M | -13.55M |
Capital Expenditures | -1.14 | -1.14 | -22K | -22K | -22K | -22K | -8K | -8K | -10K | -17K | -9K | -9K | -7K | n/a | n/a | n/a | -33K |
Cash Acquisitions | n/a | n/a | 1.91K | 1.91K | 111.98K | 111.98K | 110.07K | 110.07K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Purchase of Investments | -23.44 | -15.02K | -15.02K | -6.57M | -6.57M | -6.55M | -6.55M | -5M | -5M | -5.01M | -5.09M | -13.41M | -26.64M | -34.93M | -43.27M | -31.32M | -18.11M |
Sales Maturities Of Investments | 30K | 30K | 6.58M | 6.57M | 6.57M | 6.57M | 5M | 5M | 4.9M | 18.18M | 13.27M | 27.15M | 43.31M | 31.41M | 31.32M | 17.44M | 1.4M |
Other Investing Acitivies | -15K | -15K | -912 | -912 | -985 | -985 | -73 | -73 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Investing Cash Flow | 14.98K | -23.44 | 6.55M | -21.02K | 89K | 104K | -1.45M | 101K | -105K | 13.15M | 8.17M | 13.73M | 16.66M | -3.52M | -11.95M | -13.88M | -16.75M |
Debt Repayment | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | -1.29M | -967K | n/a | n/a | 21K | 21K | 21K | 21K | n/a | n/a | n/a | n/a | n/a | n/a | 301K | 301K | 300K |
Financial Cash Flow | 13.71M | 14.03M | 61.03K | -4.3K | 7.35M | 7.35M | 7.29M | 7.36M | 109K | 304K | 304K | 304K | 195K | n/a | 34.68M | 54.42M | 57.86M |
Net Cash Flow | 611K | -872K | -7.49M | -11.84M | -2.24M | -4.87M | -7.7M | -7.93M | -16.74M | -2.46M | -6.77M | -2M | -2.6M | -20.6M | 6.47M | 25.38M | 28.85M |
Free Cash Flow | -13.11M | -14.9M | -14.06M | -11.84M | -9.71M | -12.36M | -13.58M | -15.41M | -16.74M | -15.93M | -15.74M | -16.6M | -19.27M | -17.23M | -15.85M | -15.48M | -13.59M |